Türe, MehmetAkın, AlperDemir, MuhammedAkay, Cihan2022-03-102022-03-102022Türe, M., Akin, A., Demir, M. ve Akay, C (2022). A paediatric case of myopericarditis post-COVID-19 mRNA vaccine. Cardiology in the Young, 32(10), 1688-16911047-95111467-1107https://www.webofscience.com/wos/woscc/full-record/WOS:000757695200001https://hdl.handle.net/11468/9367WOS:000757695200001PMID: 35082004Myopericarditis is a condition, which primarily involves the pericardium, with minimal myocardial involvement. In myopericarditis, chest pain, elevated cardiac enzymes, and electrocardiographic changes occur. Although COVID-19 mRNA vaccines significantly contribute to preventing the COVID-19 disease, rarely myocarditis and/or pericarditis may develop due to these vaccines. We present a previously healthy 14-year-old male patient who developed myopericarditis after receiving the second dose of the COVID-19 mRNA vaccine.eninfo:eu-repo/semantics/openAccessmRNA vaccinesMyopericarditisCOVID-19Article321016881691WOS:0007576952000012-s2.0-851243281063508200410.1017/S1047951122000312Q3Q4